Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 6/20 | 0.33 |
| ▸ | CA1 | P00915 | 6/20 | 0.33 |
| ▸ | CA2 | P00918 | 6/20 | 0.33 |
| ▸ | CA9 | Q16790 | 6/20 | 0.33 |
| ▸ | CA7 | P43166 | 4/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93666 | 0.94 | TSHR (0.48) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL10601336 | 0.90 | TSHR (0.40) | TSHRHCAR2PDCD1CD274 | |
| Bicarbonate SCHEMBL30595887 | 0.89 | TSHR (0.43) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL11776368 | 0.88 | TSHR (0.39) | TSHRHCAR2 | |
| SCHEMBL35335 | 0.88 | TSHR (0.53) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL679600 | 0.87 | TSHR (0.42) | TSHRHCAR2CA12CA1CA2 | |
| Methyl Alcohol SCHEMBL28861340 | 0.85 | TSHR (0.50) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL4368479 | 0.85 | TSHR (0.40) | TSHRHCAR2PDCD1CD274 | |
| SCHEMBL9848011 | 0.82 | TSHR (0.39) | TSHRHCAR2 | |
| SCHEMBL9847990 | 0.82 | TSHR (0.39) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7452990-B2 | 4-halo-2-oxyimino-3-oxo butyric acid-N,N-dimethyl formiminium chloride chlorosulfate; cephalosporins that may be prepared from the intermediate include cefdinir, cefditoren pivoxil, cefepime, cefetamet pivoxil, cefixime, cefmenoxime, cefodizime, cefoselis, cefotaxime, cefpirome, cefpodoxime proxetil, etc | LUPIN LIMITED (IN) | 2008-11-18 | — | — | US | claimed |
| US-20060135761-A1 | 4-halo-2-oxyimino-3-oxo butyric acid-N,N-dimethyl formiminium chloride chlorosulfate; cephalosporins that may be prepared from the intermediate include cefdinir, cefditoren pivoxil, cefepime, cefetamet pivoxil, cefixime, cefmenoxime, cefodizime, cefoselis, cefotaxime, cefpirome, cefpodoxime proxetil, etc | LUPIN LIMITED (IN) | 2006-06-22 | — | — | US | claimed |
| EP-1575913-A1 | NOVEL INTERMEDIATES FOR SYNTHESIS OF CEPHALOSPORINS AND PROCESS FOR PREPARATION OF SUCH INTERMEDIATES | Lupin Limited (IN) | 2005-09-21 | — | — | EP | claimed |
| WO-2004058695-A1 | NOVEL INTERMEDIATES FOR SYNTHESIS OF CEPHALOSPORINS AND PROCESS FOR PREPARATION OF SUCH INTERMEDIATES | LUPIN LIMITED (IN) | 2004-07-15 | — | — | WO | claimed |
| JP-60047007-A | — | — | None | — | — | JP | disclosed |
| US-20240227256-A1 | THERMOSETTING COMPOSITION FOR INJECTION MOLDING, METHOD FOR PRODUCING MOLDED ARTICLE USING THE SAME, AND CURED PRODUCT | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240208116-A1 | THERMOSETTING COMPOSITION FOR INJECTION MOLDING, METHOD FOR PRODUCING MOLDED ARTICLE USING THE SAME, AND CURED PRODUCT | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240199782-A1 | THERMOSETTING COMPOSITION, METHOD FOR PRODUCING MOLDED ARTICLE USING THE SAME, AND CURED PRODUCT | IDEMITSU KOSAN CO.,LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| CN-115304563-A | Maleic ester modifier, polymerized acrylic resin derivative, and preparation method and application thereof | 齐河力厚化工有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-114656845-A | Super-weather-resistant nano waterproof coating formula | 浙江正恒纳米科技股份有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-111876019-B | Water-based gloss oil and preparation process thereof | 北京金印联国际供应链管理有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-111876019-A | Water-based gloss oil and preparation process thereof | 北京金印联国际供应链管理有限公司 | 2020-11-03 | — | — | CN | disclosed |
| US-6235800-B1 | Heat-expandable microcapsules and method of utilizing the same | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| EP-1067151-A1 | HEAT-EXPANDABLE MICROCAPSULES AND METHOD OF UTILIZING THE SAME | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-6110959-A | A RETINOIC ACID RECEPTOR AGONIST | EISAI CO., LTD. (JP) | 2000-08-29 | — | — | US | disclosed |
| EP-0572233-B2 | Production of thermoexpandable microcapsules | MATSUMOTO YUSHI SEIYAKU KK (JP) | 2000-03-08 | — | — | EP | disclosed |
| EP-0950923-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND FLEXOGRAPHIC RESIN PLATE | TOKYO OHKA KOGYO CO., LTD. (JP) | 1999-10-20 | — | — | EP | disclosed |
| US-5861214-A | SUSPENSION POLYMERIZING ADDITION POLYMERIZABLE UNSATURATED MONOMERS IN WATER IN PRESENCE OF ATLEAST TWO VOLATILE EXPANSION AGENTS HAVING DIFFERENT BOILING POINTS LOWER THAN SOFTENING POINT OF THERMOPLASTIC RESIN SHELL; ENCAPSULATION | MATSUMOTO YUSHI-SEIYAKU CO., LTD (JP) | 1999-01-19 | — | — | US | disclosed |
| EP-0572233-A1 | Thermoexpandable microcapsule and production | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 1993-12-01 | — | — | EP | disclosed |
| JP-S6047007-A | SUSPENSION POLYMERIZATION OF VENYL CHLORIDE MONOMER | SHIN ETSU CHEM CO LTD | 1985-03-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135761-A1 | 4-halo-2-oxyimino-3-oxo butyric acid-N,N-dimethyl formiminium chloride chlorosulfate; cephalosporins that may be prepared from the intermediate include cefdinir, cefditoren pivoxil, cefepime, cefetamet pivoxil, cefixime, cefmenoxime, cefodizime, cefoselis, cefotaxime, cefpirome, cefpodoxime proxetil, etc | CYP2F1, CYP2W1, CYP4F11 | TSHR 2523/4885HCAR2 1004/4885CA12 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.